首页> 美国卫生研究院文献>Cancer Research and Treatment : Official Journal of Korean Cancer Association >Second Primary Glioblastoma Multiforme Following Autologous Hematopoietic Stem Cell Transplantation in a Patient with Acute Myelogenous Leukemia
【2h】

Second Primary Glioblastoma Multiforme Following Autologous Hematopoietic Stem Cell Transplantation in a Patient with Acute Myelogenous Leukemia

机译:急性骨髓性白血病患者自体造血干细胞移植后的第二例原发性胶质母细胞瘤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glioblastoma multiforme (GM) is one of the most aggressive primary brain tumors, and has a poor prognosis despite intensive treatment. GM is also the most malignant astrocytoma, with histopathological features that include cellular polymorphism, rapid mitotic activity, microvascular proliferation, and necrosis. The causes of GM remain obscure, but several reports have shown associations between GM and genetic alterations and radiation exposure. Furthermore, high-dose chemotherapy/radiotherapy with autologous stem cell transplantation is increasingly being used to treat patients with leukemia, and patients who undergo stem cell transplantation have a higher risk of solid tumor cancer development later in life. Based on these associations, we discuss GM development in a patient who underwent chemoradiotherapy conditioning prior to stem cell transplantation.
机译:多形胶质母细胞瘤(GM)是最具侵略性的原发性脑肿瘤之一,尽管进行了强化治疗,但预后较差。 GM也是最恶性的星形细胞瘤,其组织病理学特征包括细胞多态性,快速有丝分裂活性,微血管增生和坏死。转基因的原因仍然不清楚,但是一些报告显示转基因与遗传改变和辐射暴露之间的关联。此外,具有自体干细胞移植的大剂量化学疗法/放射疗法正越来越多地用于治疗白血病患者,并且接受干细胞移植的患者在以后的生活中患实体瘤癌症的风险更高。基于这些关联,我们讨论了在干细胞移植之前接受放化疗的患者中的GM发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号